This page includes the latest FDA filings for Arcutis Biotherapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Arcutis Biotherapeutics, Inc. | Prescription Medication | 2025-01-19 |
Arcutis Biotherapeutics, Inc. | Prescription Medication | 2024-08-15 |
Arcutis Biotherapeutics, Inc. | Prescription Medication | 2024-07-12 |
Arcutis Biotherapeutics, Inc. | Prescription Medication | 2024-02-09 |
Arcutis Biotherapeutics, Inc. | Prescription Medication | 2024-02-07 |
Arcutis Biotherapeutics, Inc. | Prescription Medication | 2023-12-21 |
Arcutis Biotherapeutics, Inc. | Prescription Medication | 2023-10-13 |
Arcutis Biotherapeutics, Inc. | Prescription Medication | 2022-08-20 |
Arcutis Biotherapeutics, Inc. | Prescription Medication | 2022-08-10 |
ARCUTIS BIOTHERAPEUTICS, INC. | 2022-08-02 19:10:59 | |
Arcutis Biotherapeutics, Inc. | Roflumilast | 2022-07-29 |
SEC | 0001787306 | Arcutis Biotherapeutics, Inc. of DELAWARE |